CCHT Biopharmaceuticals

Alvotech & CCHT Biopharmaceutical is a China-based biopharmaceutical joint venture formed by Alvotech and Changchun High & New Technology Industries Group to develop, manufacture, register, and supply biosimilar medicines in China. Founded in March 2019, the company was established to localize Alvotech's biosimilar portfolio through a new biologics facility in Changchun Beihu Science Park. Its initial strategic focus has included biosimilars spanning autoimmune and inflammatory diseases, ophthalmology, and oncology, with commercialization support in China through a partnership with Yangtze River Pharmaceutical Group. The company appears to operate primarily as Alvotech's China biosimilars vehicle rather than as an independent discovery-stage innovator. Public information on a stand-alone pipeline, financing base, and corporate footprint is limited.